The global microbiological testing market offers significant growth potential for prominent as well as emerging product manufacturers. increased funding and public-private investments, Technological advancements and rising incidence of infectious diseases and growing outbreak of epidemics (such as COVID-19) are some of the key factors driving the growth of the microbiological testing market.
According to research report Clinical Microbiology Market is projected to reach $5.3 billion by 2025, at a CAGR of 6.5%.
The product segment owns a good market share In the clinical microbiology market. The large share of this segment is attributed to factors such as the technological advancements in the field of molecular techniques and proteomics (such as the integration of microfluidics with PCR and nanotechnology with qPCR techniques), significant adoption of conventional laboratory instruments among researchers and academia (coupled with growing industry-academia collaborations for genomic research) and the ongoing trend of laboratory automation among clinical laboratories.
BioMérieux (France), Danaher Corporation (US), Becton, Abbott Laboratories (US), and Roche Diagnostics (Switzerland), Dickinson and Company (US), . Other prominent players include Thermo Fisher Scientific (US), QIAGEN (Netherlands), 3M (US), Bio-Rad Laboratories (US), Bruker Corporation (US), and Hologic (US).
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=219135367